ANDREW GONZALEZ: Open Payments
NPI 1972234334 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 37 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $482 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $217 |
| Merck Sharp & Dohme LLC | 6 | $109 |
| PFIZER INC. | 4 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $75 |
| CVRx, Inc. | 3 | $65 |
| Actelion Pharmaceuticals US, Inc. | 2 | $60 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| ABIOMED | 2 | $40 |
| Boston Scientific Corporation | 1 | $32 |
| Novo Nordisk Inc | 1 | $28 |
Products named: JARDIANCE, ELIQUIS, VERQUVO, Kerendia, Barostim Neo System, UPTRAVI, General - Therapies, CAMZYOS.
Industry payments across FL — which companies pay providers there.
